- Current report filing (8-K)
January 21 2011 - 3:22PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): January 14, 2011
ProUroCare
Medical Inc.
(Exact
Name of Registrant as Specified in its Charter)
Nevada
|
000-51774
|
20-1212923
|
(State
or other jurisdiction
|
(Commission
|
(IRS
Employer
|
of
incorporation)
|
File
Number)
|
Identification
No.)
|
|
6440 Flying Cloud Dr.,
Suite 101, Eden Prairie,
Minnesota 55416
|
(Address
of Principal Executive Offices) (Zip Code)
|
|
(952)
476-9093
|
(Registrant’s
Telephone Number, Including Area Code)
|
|
Not
Applicable
|
(Former
Name or Former Address, if Changed Since Last Report)
|
|
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
|
|
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
o
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item 1.01
Entry into
Material Definitive Agreements
On
January 14, 2011, ProUroCare Medical Inc. (the “Company”) renewed its existing
$100,025 promissory note with Central Bank for an additional one-year
term. The promissory note matures on January 17, 2012 and bears
interest at the Prime Rate plus 1.0%, with a minimum rate of
6.0%. The promissory note remains guaranteed by Bruce
Johnson. The Company’s existing security agreement with Mr. Johnson,
which provides him with a subordinated security interest in the Company’s
assets, will remain in effect until the Central Bank promissory note is
retired.
Item
2.03 Creation of a Direct financial Obligation or an Obligation under
an Off-Balance Sheet Arrangement of the Company
See Item
1.01 above.
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the Registrant has duly caused this Report on
Form 8-K to be signed on its behalf by the undersigned hereunto duly
authorized.
|
ProUroCare
Medical Inc.
|
|
|
|
|
|
Date:
January 21, 2011
|
By
|
/s/
Richard C. Carlson
|
|
|
|
Richard
C. Carlson
|
|
|
|
Chief
Executive Officer
|
|
|
|
|
|
ProUroCare Medical (CE) (USOTC:PUMD)
Historical Stock Chart
From May 2024 to Jun 2024
ProUroCare Medical (CE) (USOTC:PUMD)
Historical Stock Chart
From Jun 2023 to Jun 2024